Written answers
Wednesday, 6 October 2021
Department of Health
Medicinal Products
Colm Burke (Cork North Central, Fine Gael)
Link to this: Individually | In context | Oireachtas source
148. To ask the Minister for Health if his Department and the HSE will review the decision not to allow for reimbursement of cannabidiol, epidiolex in view of the fact that there has been clear evidence to show that this drug is extremely effective in the management of care for patients with dravet syndrome and lennox-gastaut syndrome; and if he will make a statement on the matter. [48542/21]
Stephen Donnelly (Wicklow, Fianna Fail)
Link to this: Individually | In context | Oireachtas source
The HSE has statutory responsibility for decisions on pricing and reimbursement of medicines under the community drugs schemes, in accordance with the Health (Pricing and Supply of Medical Goods) Act 2013. As this is a service matter, I have asked the Health Service Executive to respond to the deputy directly, as soon as possible.
No comments